BP-CT (Osteometabolix Pharmaceuticals)

N/A

Report date: 2025/03/14 16:23:24
NME

Base Information

Drug NameBP-CT (Osteometabolix Pharmaceuticals)
Drug Alias Namebisphosphonate conjugated calcitonin (Osteometabolix Pharmaceuticals)BP-CT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBone modulators
TargetsUpdating
Therapy Area/IndicationsOsteoarthritisOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOsteometabolix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOsteometabolix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritisOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A